Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Guardant Health is joining in on the American Lung Association’s (ALA’s) push to raise awareness about lung cancer screening and biomarker testing. The U.S. Preventive Services Task Force recommends ...

A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis - in ...

Biodesix, Inc. has announced that new research will be showcased at upcoming conferences, including the ISPOR 2025 Annual Meeting in Montreal and the ATS 2025 International Conference in San Francisco ...

In this first part of an interview with The American Journal of Managed Care®, Julia Rotow, MD, thoracic oncologist at Dana-Farber Cancer Institute, discusses the critical need to test for biomarkers ...

Credit: Getty Images The road to race-neutral pulmonary function testing has been long and evolving; now, ATS recommends this approach and a Boston hospital offers an implementation model. In July, ...

Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is ...

Credit: Getty Images A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care. Pulmonary function testing ...

AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

What if a simple blood test could tell you that lung cancer might develop years before it actually appears? It sounds like ...